5441722025-10-012025-12-315441722025-12-315441722025-10-012025-12-31CompositionOfBoardOfDirectors15441722025-12-31CompositionOfBoardOfDirectors15441722025-10-012025-12-31CompositionOfBoardOfDirectors25441722025-12-31CompositionOfBoardOfDirectors25441722025-10-012025-12-31CompositionOfBoardOfDirectors35441722025-12-31CompositionOfBoardOfDirectors35441722025-10-012025-12-31CompositionOfBoardOfDirectors45441722025-12-31CompositionOfBoardOfDirectors45441722025-10-012025-12-31CompositionOfBoardOfDirectors55441722025-12-31CompositionOfBoardOfDirectors55441722025-10-012025-12-31CompositionOfBoardOfDirectors65441722025-12-31CompositionOfBoardOfDirectors65441722025-10-012025-12-31CompositionOfBoardOfDirectors75441722025-12-31CompositionOfBoardOfDirectors75441722025-10-012025-12-31CompositionOfBoardOfDirectors85441722025-12-31CompositionOfBoardOfDirectors85441722025-10-012025-12-31CompositionOfBoardOfDirectors95441722025-12-31CompositionOfBoardOfDirectors95441722025-10-012025-12-31CompositionOfCommittees145441722025-12-31CompositionOfCommittees145441722025-10-012025-12-31CompositionOfCommittees155441722025-12-31CompositionOfCommittees155441722025-10-012025-12-31CompositionOfCommittees165441722025-12-31CompositionOfCommittees165441722025-10-012025-12-31CompositionOfCommittees175441722025-12-31CompositionOfCommittees175441722025-10-012025-12-31CompositionOfCommittees415441722025-12-31CompositionOfCommittees415441722025-10-012025-12-31CompositionOfCommittees425441722025-12-31CompositionOfCommittees425441722025-10-012025-12-31CompositionOfCommittees435441722025-12-31CompositionOfCommittees435441722025-10-012025-12-31CompositionOfCommittees445441722025-12-31CompositionOfCommittees445441722025-10-012025-12-31CompositionOfCommittees455441722025-12-31CompositionOfCommittees455441722025-10-012025-12-31CompositionOfCommittees685441722025-12-31CompositionOfCommittees685441722025-10-012025-12-31CompositionOfCommittees695441722025-12-31CompositionOfCommittees695441722025-10-012025-12-31CompositionOfCommittees705441722025-12-31CompositionOfCommittees705441722025-10-012025-12-31CompositionOfCommittees955441722025-12-31CompositionOfCommittees955441722025-10-012025-12-31CompositionOfCommittees965441722025-12-31CompositionOfCommittees965441722025-10-012025-12-31CompositionOfCommittees975441722025-12-31CompositionOfCommittees975441722025-10-012025-12-31CompositionOfCommittees985441722025-12-31CompositionOfCommittees985441722025-10-012025-12-31CompositionOfCommittees1225441722025-12-31CompositionOfCommittees1225441722025-10-012025-12-31CompositionOfCommittees1235441722025-12-31CompositionOfCommittees1235441722025-10-012025-12-31CompositionOfCommittees1245441722025-12-31CompositionOfCommittees1245441722025-10-012025-12-31CompositionOfCommittees1255441722025-12-31CompositionOfCommittees1255441722025-10-012025-12-31CompositionOfCommittees1495441722025-10-012025-12-31CompositionOfCommittees1505441722025-10-012025-12-31CompositionOfCommittees1515441722025-10-012025-12-31CompositionOfCommittees1525441722025-12-31MeetingOfBoardOfDirectors15441722025-10-012025-12-31MeetingOfBoardOfDirectors15441722025-12-31MeetingOfBoardOfDirectors25441722025-10-012025-12-31MeetingOfBoardOfDirectors25441722025-10-012025-12-31MeetingOfCommittees15441722025-12-31MeetingOfCommittees15441722025-10-012025-12-31MeetingOfCommittees25441722025-12-31MeetingOfCommittees25441722025-10-012025-12-31MeetingOfCommittees35441722025-12-31MeetingOfCommittees35441722025-10-012025-12-31MeetingOfCommittees45441722025-12-31MeetingOfCommittees45441722025-09-305441722025-12-31UnlistedCompanyDomain15441722025-10-012025-12-31UnlistedCompanyDomain15441722025-09-30UnlistedCompanyDomain15441722025-12-31UnlistedCompanyDomain25441722025-10-012025-12-31UnlistedCompanyDomain25441722025-09-30UnlistedCompanyDomain25441722025-12-31UnlistedCompanyDomain35441722025-10-012025-12-31UnlistedCompanyDomain35441722025-09-30UnlistedCompanyDomain3xbrli:pure544172INDGNNOTLISTEDINE065X01017Indegene Limited2025-04-012026-03-31Quarterly2025-12-31EquitytruetruetruefalseNOT APPLICABLEfalseNOT APPLICABLEtrueTop 500 listed entitiestrueCOM100542OriginaltruetrueMrManish Gupta******00219273Executive DirectorChairpersonCEO1972-12-09falseActiveNA2000-02-112022-11-031000MrSanjay Suresh Parikh******00219278Executive DirectorNot Applicable1963-10-02falseActiveNA2002-01-292002-01-291020MrRajesh Bhaskaran Nair******00219269Non-Executive - Non Independent DirectorNot Applicable1970-05-25falseActiveNA1998-10-162016-02-291010MrMark Francis Dzialga******00955485Non-Executive - Non Independent DirectorNot Applicable1964-10-01falseActiveNA2021-04-162021-04-161000NOT APPLICABLEMrKrishnamurthy Venugopala Tenneti******01338477Non-Executive - Independent DirectorNot Applicable1945-06-29falseActiveYes2022-11-282022-07-282024-07-28412131MrAshish Gupta******00521511Non-Executive - Independent DirectorNot Applicable1966-12-18falseActiveNo2022-04-282025-04-28443300MrJairaj Manohar Purandare******00159886Non-Executive - Independent DirectorNot Applicable1959-06-30falseActiveNo2022-04-282025-04-28444474MrPravin Udhyavara Bhadya Rao******06782450Non-Executive - Independent DirectorNot Applicable1961-12-12falseActiveNo2022-06-082025-06-08434461MsGeorgia Nikolakopoulou Papathomas******09734940Non-Executive - Independent DirectorNot Applicable1950-09-11falseActiveYes2025-06-262022-09-302025-10-01391100NOT APPLICABLEtruetruetruetruetrueAudit Committee00159886Jairaj Manohar PurandareNon-Executive - Independent DirectorChairperson2022-11-03Audit Committee00219278Sanjay Suresh ParikhExecutive DirectorMember2022-11-03Audit Committee06782450Pravin Udhyavara Bhadya RaoNon-Executive - Independent DirectorMember2022-11-03Audit Committee01338477Krishnamurthy Venugopala TennetiNon-Executive - Independent DirectorMember2022-11-03Nomination and remuneration committee01338477Krishnamurthy Venugopala TennetiNon-Executive - Independent DirectorChairperson2022-11-03Nomination and remuneration committee06782450Pravin Udhyavara Bhadya RaoNon-Executive - Independent DirectorMember2022-11-03Nomination and remuneration committee00955485Mark Francis DzialgaNon-Executive - Non Independent DirectorMember2022-11-03Nomination and remuneration committee00521511Ashish GuptaNon-Executive - Independent DirectorMember2022-11-03Nomination and remuneration committee00159886Jairaj Manohar PurandareNon-Executive - Independent DirectorMember2022-12-09Stakeholders Relationship Committee00159886Jairaj Manohar PurandareNon-Executive - Independent DirectorChairperson2022-11-03Stakeholders Relationship Committee00219278Sanjay Suresh ParikhExecutive DirectorMember2022-11-03Stakeholders Relationship Committee00219269Rajesh Bhaskaran NairNon-Executive - Non Independent DirectorMember2022-11-03Risk Management Committee00219273Manish GuptaExecutive DirectorChairperson2025-02-23Risk Management Committee00219269Rajesh Bhaskaran NairNon-Executive - Non Independent DirectorMember2025-02-23Risk Management Committee00219278Sanjay Suresh ParikhExecutive DirectorMember2025-02-23Risk Management Committee06782450Pravin Udhyavara Bhadya RaoNon-Executive - Independent DirectorMember2025-02-23Corporate Social Responsibility Committee00219273Manish GuptaExecutive DirectorChairperson2015-02-04Corporate Social Responsibility Committee00219269Rajesh Bhaskaran NairNon-Executive - Non Independent DirectorMember2015-02-04Corporate Social Responsibility Committee00219278Sanjay Suresh ParikhExecutive DirectorMember2015-02-04Corporate Social Responsibility Committee06782450Pravin Udhyavara Bhadya RaoNon-Executive - Independent DirectorMember2022-11-03Other Committee01338477Krishnamurthy Venugopala TennetiInvestment CommitteeNon-Executive - Independent DirectorChairpersonOther Committee00521511Ashish GuptaInvestment CommitteeNon-Executive - Independent DirectorMemberOther Committee00955485Mark Francis DzialgaInvestment CommitteeNon-Executive - Non Independent DirectorMemberOther Committee00219269Rajesh Bhaskaran NairInvestment CommitteeNon-Executive - Non Independent DirectorMember2025-07-31true9952025-10-3090true995Audit Committee2025-07-29true4439Audit Committee2025-10-2991true4439Other Committee2025-07-14Investment Committeetrue5525Risk Management Committee2025-08-2642true4415truetruetruetrueYestruetruetrueSrishti Ramesh KaushikCompany Secretary and Compliance OfficerfalseSrishti Ramesh KaushikCompany Secretary and Compliance OfficerBangalore2026-01-2003300Trilogy Writing & Consulting Inc. - Please refer to our intimation dated December 31, 2025, wherein we informed that Indegene, Inc. (USA), a wholly owned subsidiary of the Company, acquired 100% of the equity shares of Trilogy Writing & Consulting Inc. (formerly Trilogy Writing and Consulting ULC, Canada) (Target Company), which was a wholly owned subsidiary of Trilogy Writing and Consulting GmbH. Pursuant to this acquisition, Trilogy Writing & Consulting Inc. ceased to be a subsidiary of Trilogy Writing and Consulting GmbH and became a wholly owned subsidiary of Indegene, Inc. Further, on January 1, 2026, we informed that the Companys step-down subsidiariesIndegene Aptilon Services, Inc. and Trilogy Writing & Consulting Inc. (formerly Trilogy Writing and Consulting ULC, Canada)both wholly owned by Indegene, Inc. (USA), amalgamated on January 01, 2026, to form Indegene Healthcare Canada Inc. Cake Group - Date of acquisition is the date of intimation i.e. November 10, 2025 wherein we informed that the Companys wholly owned subsidiary, Indegene Ireland Limited on 10th November 2025 signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in Cake Kommunikations Holding GmbH (an SPV created to hold 70% in Cake Kommunikations GmbH (AT), 100% in CAKE Kommunikations GmbH (DE) and 100% in CAKE Kommunikations AG (Switzerland)) and 30% in Cake Kommunikations GmbH (AT) [Collectively Cake Group]. Warn and Co Limited - Please refer our intimation October 17, 2025 wherein we informed that Companys wholly owned subsidiary, Indegene Ireland Limited has, on October 16, 2025 , signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in Warn And Co Limited. Regarding acquisition of BioPharm Parent Holding, Inc., please refer our integrated governance filed for Q2 FY26 and intimation dated October 01, 2025 wherein we informed that the Companys wholly owned subsidiary, Indegene Ireland Limited has, on September 30, 2025, signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in BioPharm Parent Holding, Inc. along with its subsidiaries (collectively, BioPharm).Trilogy Writing & Consulting Inc.2025-12-31011Cake Group2025-11-10011Warn and Co Limited2025-10-17011